Tyche Industries LtdPharmaceuticalsINE443B01012
Valuation
Market Cap₹117.31 Cr
TTM PE26.74x
Forward PE30.77x
PEG-28.75
Book Value₹190.75
P/B0.60x
TTM EPS₹4.28
Fwd EPS₹3.72
TTM Revenue₹50.04 Cr
TTM PAT₹4.44 Cr
TTM EBITDA₹-1.40 Cr
TTM EBIT₹-3.56 Cr
Last Qtr PAT₹1.15 Cr
Last Qtr EBITDA₹-1.70 Cr
Last Qtr EBIT₹-2.32 Cr
Profitability
ROE—
ROCE—
TTM NPM8.87%
TTM EBITDA %-2.80%
Curr OPM-0.59%
Last OPM7.13%
Curr NPM—
Last NPM—
Curr EPS₹-0.04
Last EPS₹1.05
Balance sheet
Equity—
Reserve—
Total Debt₹0.00 Cr
D/E—
Interest %0.00%
Curr Interest₹0.00 Cr
Price / range
Close₹114.45
vs 52W High-22.67%
vs 52W Low+15.61%
MA50—
MA200—
Returns
1D+3.15%
1W+5.05%
1M+10.05%
3M-10.83%
6M+5.83%
1Y-20.19%
2Y-41.89%
3Y-31.94%
5Y-42.30%
Diwali-0.95%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
0 lines · 0 periodsNo financial result data.
Yearly results
Last 6 financial years · YoY % vs previous FY
Yearly
0 lines · 0 yearsNo yearly result data.
Corporate Actions
Dividends, bonus issues, and stock splits